ELV
Elevance Health Inc.NYSEHealthcare$300.74+0.75%OpenMarket Cap: $66.37B
As of 2026-04-06
Valuation
P/E (TTM)
11.72
PEG
—
P/B
1.52
P/S
0.33
EV/EBITDA
9.33
DCF Value
$1,503.82
FCF Yield
4.8%
Div Yield
2.3%
Margins & Returns
Gross Margin
25.6%
Operating Margin
4.1%
Net Margin
2.8%
ROE
13.0%
ROA
6.9%
ROIC
6.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $49.75B | 23.5% | $581.0M | $547.0M | $2.47 | $1.71 |
| FY 2025 | $199.13B | 25.6% | $8.11B | $5.66B | $25.12 | $6.84 |
| Q3 2025 | $50.71B | 24.8% | $1.76B | $1.19B | $5.32 | $1.71 |
| Q2 2025 | $49.78B | 26.3% | $2.63B | $1.74B | $7.72 | $1.71 |
| Q1 2025 | $48.89B | 27.8% | $3.14B | $2.18B | $9.61 | $1.71 |
| Q4 2024 | $45.44B | 26.3% | $946.0M | $418.0M | $1.81 | $1.63 |
| FY 2024 | $176.81B | 27.9% | $8.89B | $5.98B | $25.68 | $6.52 |
| Q3 2024 | $45.15B | 27.0% | $1.71B | $1.02B | $4.36 | $1.63 |
| Q2 2024 | $43.65B | 30.0% | $3.03B | $2.30B | $9.85 | $1.63 |
| Q1 2024 | $42.58B | 28.3% | $3.20B | $2.25B | $9.59 | $1.63 |
| Q4 2023 | $42.65B | 26.5% | $1.26B | $856.0M | $3.63 | $1.48 |
| FY 2023 | $171.34B | 27.4% | $8.74B | $5.99B | $25.22 | $5.92 |